Professor of Medicine, Tulane University
Endocrinology
Dr. Vivian A. Fonseca, MD
|
|
Give Review
Dr. Vivian A. Fonseca practices Endocrinology. He attended Tulane University School of Medicine. He has 4 awards "Regional Top Doctor", "CMS Meaningful Use Stage 1 Certification", "Super Doctor" and "Fellow (FACE)". Vivian Fonseca is a published doctor as well. He has 31 publications published. The latest was: PAX4 Gene Transfer Induces -to- Cell Phenotypic Conversion and Confers Therapeutic Benefits for Diabetes Treatment. He is registered with Medicare.
Publications
- PAX4 Gene Transfer Induces α-to-β Cell Phenotypic Conversion and Confers Therapeutic Benefits for Diabetes Treatment.
- GLYCATED ALBUMIN AT 4 WEEKS CORRELATES With A1C LEVELS AT 12 WEEKS AND REFLECTS SHORT-TERM GLUCOSE FLUCTUATIONS.
- Effect of paricalcitol on endothelial function and inflammation in type 2 Diabetes and chronic kidney disease.
- Association between hypoglycemia and fall-related events in type 2 Diabetes mellitus: analysis of a u.s. Commercial database.
- Role of Insulin Sensitizers on Cardiovascular Risk Factors in Polycystic Ovarian Syndrome: A Meta-Analysis.
- Progressive change of intra-islet GLP-1 production during Diabetes development.
- Triple combination of insulin glargine, sitagliptin and metformin in type 2 Diabetes: The EASIE post-hoc analysis and extension trial.
- From guideline to patient: a review of recent recommendations for pharmacotherapy of painful Diabetic neuropathy.
- Reduced risk of hypoglycemia With once-daily glargine versus twice-daily NPH and number needed to harm With NPH to demonstrate the risk of one additional hypoglycemic ...
- New Developments in Diabetes Management: Medications of the 21st Century.
- Achieving glycaemic targets With basal insulin in T2DM by individualizing treatment.
- Reductions in systolic blood pressure with liraglutide in patients with type 2 Diabetes: Insights from a patient-level pooled analysis of six randomized clinical trials.
- The Impact of Salsalate Treatment on Serum Levels of Advanced Glycation End Products in Type 2 Diabetes.
- How to get your paper published paper: An editor's perspective.
- Targeting Inflammation Using Salsalate in Patients With Type 2 Diabetes (TINSAL): Effects on flow-mediated dilation.
- Efficacy and safety of initial combination treatment With sitagliptin and pioglitazone - a factorial study.
- Clinical and Economic Benefits Associated With the Achievement of Both HbA1c and LDL Cholesterol Goals in Veterans With Type 2 Diabetes Mellitus.
- Relationships among symptomatic hypoglycemia, patient-reported fear of hypoglycemia and health-related quality of life (hrqol) in type-2 Diabetes mellitus (t2dm) patie...
- Economic outcomes associated with hba1c and ldl-C goal achievement in patients with type 2 Diabetes mellitu.
- Diabetes mellitus in the next decade: novel pipeline medications to treat hyperglycemia.
- Efficacy and safety of sitagliptin added to ongoing metformin and pioglitazone combination therapy in a randomized, placebo-controlled, 26-week trial in patients With ...
- Determinants of weight gain in the action to control cardiovascular risk in Diabetes trial.
- Metanx in type 2 Diabetes with peripheral neuropathy: a randomized trial.
- Active- and placebo-controlled dose-finding study to assess the efficacy, safety, and tolerability of multiple doses of ipragliflozin in patients with type 2 Diabetes ...
- Comparing Diabetes drugs-helping clinical decisions?
- Glucose control and cardiovascular outcomes in individuals with Diabetes mellitus: lessons learned from the megatrials.
- Cardiovascular Benefits of Exogenous Insulin.
- The American Diabetes Association Diabetes research perspective.
- Efficacy and safety of the once-daily GLP-1 receptor agonist lixisenatide in monotherapy: a randomized, double-blind, placebo-controlled trial in patients with Type 2 ...
- Physician practice behavior and practice guidelines: using unannounced standardized patients to gather data.
Schools
Armed Forces Medical College Maharashtra University Of Health Sciences
KEM Hospital
Jj Hospital
Royal College Of Physicians
Royal Free Hospital
Conditions Treated
- Abnormal Thyroid
- Adrenal Incidentaloma
- Adrenal Insufficiency
- Cushing's Syndrome
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
- Super Doctor
- Fellow (FACE)
Education
-
Tulane University School of Medicine
Drug Facts
| NPI NUMBER | 1346356037 | |
| NPPES Provider LastName | FONSECA | |
| NPPES Provider FirstName | VIVIAN | |
| NPPES Provider ZIPCode | 701122632 | |
| NPPES Provider State | LA | |
| Specialty Description | Emergency Medicine | |
| Total Claim Count | 1348.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1346356037 |
| Last Name Of The Provider | FONSECA |
| First Name Of The Provider | VIVIAN |
| View All |
Similar Doctors
|
|
Dr. Cyril Y. Bowers, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Alan L. Burshell, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Samuel S. Andrews II, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Olga Kaliebe, MD
This Doctor is OpenDoctor Recommended.
|